Selenoproteins exist within all three domains of life. It is estimated that one‐third of prokaryotes utilize selenium for specific biological purposes, whereas the majority of microorganisms do not use or need selenium. Selenoproteins are unique proteins in which selenocysteine is inserted into the polypeptide chain by highly specialized translational machinery. Alternatively, some selenoproteins in which selenium is incorporated as a labile cofactor have been characterized, and this class of selenoproteins also contains either molybdenum or tungsten. Although several selenoproteins have been well characterized for several decades, the biological functions of these proteins are still being defined. The role of selenoproteins, particularly in human pathogens, has received little attention, yet there is evidence that targeting such proteins could play a major role in drug development. In addition, emerging evidence suggests that many well‐known cancer drugs target a specific class of selenoproteins in mammals, lending credence to the notion that selenoproteins may indeed already be substantial drug targets in the clinic.